DK3463310T3 - Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte - Google Patents

Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte Download PDF

Info

Publication number
DK3463310T3
DK3463310T3 DK17726906.5T DK17726906T DK3463310T3 DK 3463310 T3 DK3463310 T3 DK 3463310T3 DK 17726906 T DK17726906 T DK 17726906T DK 3463310 T3 DK3463310 T3 DK 3463310T3
Authority
DK
Denmark
Prior art keywords
omega
tablets
active ingredient
amino acid
ingredient content
Prior art date
Application number
DK17726906.5T
Other languages
English (en)
Inventor
Thomas Gottstein
Günter Knaup
Michael Schwarm
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Application granted granted Critical
Publication of DK3463310T3 publication Critical patent/DK3463310T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
DK17726906.5T 2016-05-25 2017-05-24 Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte DK3463310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171296 2016-05-25
PCT/EP2017/062592 WO2017202942A1 (en) 2016-05-25 2017-05-24 Tablets with high active ingredient content of omega-3 fatty acid amino acid salts

Publications (1)

Publication Number Publication Date
DK3463310T3 true DK3463310T3 (da) 2023-09-25

Family

ID=56081305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17726906.5T DK3463310T3 (da) 2016-05-25 2017-05-24 Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte

Country Status (9)

Country Link
US (1) US20200315970A1 (da)
EP (1) EP3463310B1 (da)
AU (1) AU2017270134B2 (da)
CA (1) CA3025425A1 (da)
DK (1) DK3463310T3 (da)
ES (1) ES2956766T3 (da)
PL (1) PL3463310T3 (da)
TW (1) TW201808274A (da)
WO (1) WO2017202942A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021023850A1 (en) * 2019-08-08 2021-02-11 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) * 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
TW202120076A (zh) * 2019-08-08 2021-06-01 德商贏創運營有限公司 用於製造多不飽和脂肪酸鹽之下游製程
WO2021023857A1 (en) * 2019-08-08 2021-02-11 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
CN111067876B (zh) * 2019-12-04 2022-08-16 宁夏大学 一种α-亚麻酸双层片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form

Also Published As

Publication number Publication date
ES2956766T3 (es) 2023-12-27
PL3463310T3 (pl) 2023-12-04
TW201808274A (zh) 2018-03-16
EP3463310B1 (en) 2023-07-05
CA3025425A1 (en) 2017-11-30
AU2017270134A1 (en) 2018-12-06
US20200315970A1 (en) 2020-10-08
WO2017202942A1 (en) 2017-11-30
EP3463310A1 (en) 2019-04-10
AU2017270134B2 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
DK3463310T3 (da) Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte
DK3273942T3 (da) Mikronåleplaster til indgivelse af en aktiv bestanddel til huden
CL2016002300A1 (es) Combinaciones de principios activos insecticidas y nematocidas
EP3735963C0 (en) SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACIDS
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
DK3236782T3 (da) Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3355856T3 (da) Oralt administrerede aminosyreformuleringer med modificeret udløsning
PT3346835T (pt) Composição de inseticida/acaricida à base de sais de ácidos gordos
DK2996484T3 (da) Anvendelse af talloliefedtsyre
DK3256483T3 (da) Hidtil ukendt c-3-triterpenon med omvendte c-17-amidderivater som hiv-hæmmere patentkrav
DK3544584T3 (da) Farmaceutisk parenteral formulering indeholdende cargluminsyre
DK2981258T3 (da) Farmaceutiske formuleringer til subkutan indgivelse af furosemid
CY1123877T1 (el) Μορφες στερεας καταστασης αλατων νιλοτινιμπης
FR3039396B1 (fr) Base de formulation cosmetique concentree
IL263982B (en) Preparations with two ingredients containing acetylsalicylic acid and sea salt of organic acids
DK2886108T4 (da) Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus
DK3400017T3 (da) Kontinuerlig kompleksering af aktive farmaceutiske ingredienser
DK3307239T3 (da) Formuleringer til indgivelse af RSV- og norovirusantigener i tyndtarmen
DK3286190T3 (da) Farmaceutiske saltformer af en inhibitor af semicarbazid-sensitiv aminoxidase (ssao)
DK3402573T3 (da) Aminosyreholdig sammensætning
DK3173071T3 (da) Formularing af maropitant
DK3319980T3 (da) Formuleringer til forbedring af virkningen af hydrofobe lægemidler
MA43126A (fr) Compositions pharmaceutiques de fumarate de diméthyle
MA43166A (fr) Formulation de fviii